Clinical Trial Update: The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the impact of omega-3 fat emulsion on clinical outcomes in postoperative cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Omega-3 Fat Emulsion (omega-3 fatty acid emulsion)

Snippet

Sponsor: Sino-Swed Pharmaceutical Corporation | Conditions: Carcinoma Surgery, Parenteral Nutrition | Phase 3 | Status: COMPLETED